Opinions expressed by Entrepreneur contributors are their own.
You’re reading Entrepreneur India, an international franchise of Entrepreneur Media.
For a long time pharma marketing was all about pharma brands getting in touch with their target audience – doctors physically. But the process involved a lot of inefficiencies both in terms of the time and money spent. But Doceree changed the game.
As there has been a gradual rise of Health Care Professionals (HCP)-only digital platforms such as medical education sites, networking sites, medical associations, and medical journals that HCPs visit to advance their professional knowledge or to connect with their peer group – on the back of their partnership with specialized ad exchanges, pharma messaging can be presented to targeted HCPs based on their search/ need on the endemic sites through programmatic tools. These tools ensure that an advertisement which is meant for physicians of a particular specialty is seen by them only, thereby reducing inefficiencies.
With the help of its proprietary AI engine, Espyian, Doceree has already targeted over 1 million physicians across the US. The number is close to 3 lakh in India.
The start-up is profitable across markets, and has grown more than 100% in the last one year with monthly revenue rising five-fold between the Series A funding in April 2022 and now.
The company recently raised $35 million in Series B, and is striving towards expanding significantly across the globe in the next two years.
TECH SPECS
•Year of inception: 2019
•No. of employees: 100+
•External funding received so far: $48 million
•Major clients: Working with top 10 pharma brands, globally.
•Any IP developed/ patented: ESPIYAN
This article is from Entrepreneur.com
